Cara Therapeutics, Inc.
Cara Therapeutics, Inc. (CARA) is a publicly traded company in the Unknown sector. Across all available filings, 23 corporate insiders have executed 344 transactions totaling $47.5M, demonstrating a bearish sentiment with -$8.9M in net insider flow. The most recent transaction on Aug 1, 2024 involved a sale of 4,149 shares valued at $1.5K.
CARA Insider Activity Summary
Who Is Buying CARA Stock?
No significant insider buying has been recorded for CARA in the recent period.
Who Is Selling CARA Stock?
No significant insider selling has been recorded for CARA in the recent period.
Is Cara Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CARA is bearish with an Insider Alignment Score of 41/100 and a net flow of -$8.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
CARA Frequently Asked Questions
Understanding CARA Insider Activity
Insider trading at Cara Therapeutics, Inc. (CARA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 23 insiders are actively trading CARA stock, having executed 344 transactions in the past 90 days. The most active insider is Mark Leschly (Executive), who has made 3 transactions totaling $11.6M.
Related Tools
Track Cara Therapeutics, Inc. Insider Activity
Get notified when executives and directors at CARA file new Form 4 transactions